Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

13.22
Delayed Data
As of Jun 28
 +0.70 / +5.59%
Today’s Change
12.05
Today|||52-Week Range
28.74
-30.31%
Year-to-Date

Today’s Trading

Previous close12.52
Today’s open13.09
Day’s range13.01 - 13.42
Volume379,399
Average volume (3 months)187,344
Market cap$274.3M
Dividend yield5.05%
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+45.14%
Earnings growth (this year)-36.30%
Earnings growth (next 5 years)+274.70%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
COLLCollegium Pharmaceut...+0.55+4.71%
AKBAAkebia Therapeutics ...+0.43+5.94%
CRVSCorvus Pharmaceutica...+0.61+4.57%
TBRATobira Therapeutics ...-1.07-7.46%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$1.67
Annual revenue (last year)$0.00
Annual profit (last year)-$70.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs